BiotechTube
Home/Mochida Pharmaceutical/Koji Mochida
KM

Koji Mochida

Representative Director and Senior Managing Executive Officer

Mochida Pharmaceutical

Therapeutic Areas

OncologyImmunology & InflammationDermatologyGastroenterology

Mochida Pharmaceutical Pipeline

DrugIndicationPhase
Fostamatinib (TAK-079 / MND-379)Chronic Immune Thrombocytopenia (ITP)Launched
MO-825Atopic DermatitisPhase 3
MO-728Ulcerative ColitisPhase 2
MO-858Solid TumorsPhase 1/2

Leadership Team at Mochida Pharmaceutical

DT
Dr. Toshihiko Oba
Representative Director and President
View full Mochida Pharmaceutical profile